Morningstar Quantitative ratings for equities (denoted on this page by) are generated using an algorithm that compares companies that are not under analyst coverage to peer companies that do receive analyst-driven ratings. Companies withratings are not formally covered by a Morningstar analyst, but are statistically matched to analyst-rated companies, allowing our models to calculate a quantitative moat, fair value, and uncertainty rating. Click here for more on how to use these ratings.
Positron Corp is a US-based nuclear medicine healthcare company. It operates in the field of cardiac Positron Emission Tomography (PET) imaging - the gold standard diagnostic test in nuclear cardiology. The cardiac PET is the superior method in diagnostic nuclear imaging for the detection of coronary artery disease, a leading cause of death in the United States. It offers Positron Emission Tomography imaging system, clinical and support services, radiopharmaceuticals, and radioisotope processing and production. Based on product lines, manufacturing processes, marketing and management of businesses, it operates through medical equipment and radiopharmaceuticals segments. The company derives revenues from the sale of medical equipment products, maintenance contracts, and service revenues.